1 – 10 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Acute myeloid leukemia in very old patients
- 2017
- The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia
- Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia : A population-based study from the Swedish AML registry
- Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register
- 2016
- Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence.
- Cardiovascular events associated with use of tyrosine kinase inhibitors in chronic myeloid leukemia
- Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
- 2015
- Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib
- The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses
- Prognostic significance of high hyperdiploid and tri-/tetraploid adult acute myeloid leukemia.